Prospective Trial Comparing the Use of Sulphasalazine and Auranofin as Second Line Drugs in Patients With Rheumatoid Arthritis.
Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.51.4.461
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 1992
Authors
Publisher
BMJ